Gary R. Sitko - Concepedia

Concepedia

Author

Gary R. Sitko

United States Military Academy

Also Known As

G R Sitko, G. R. SITKO, G. R. Sitko, G.R. Sitko, Gary R Sitko, Gary R. Sitko, Gary Sitko

38

Publications

1.1K

Citations

19

H-Index

33

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)

GR

About

Gary R. Sitko is an author at United States Military Academy specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	523
2	Biochemistry	7	7	315
3	Natural Sciences	5	5	272
4	Biomedical Engineering	2	2	117
5	Allergy	1	1	28

Gary R. Sitko

×

24

Publications

1.1K

Citations

19

H-Index

	Year	Citations
Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis. Gary R. Sitko, Denise Ramjit, Inez I. Stabilito, Circulation	1992	131
Metabolism-Directed Optimization of 3-Aminopyrazinone Acetamide Thrombin Inhibitors. Development of an Orally Bioavailable Series Containing P1 and P3 Pyridines Christopher S. Burgey, Kyle A. Robinson, Terry A. Lyle, Journal of Medicinal Chemistry Pharmaceutical ScienceOral BioavailabilityPharmacotherapyPharmaceutical ChemistryMolecular Pharmacology	2003	120
An Antibody Against the Exosite of the Cloned Thrombin Receptor Inhibits Experimental Arterial Thrombosis in the African Green Monkey Jacquelynn J. Cook, Gary R. Sitko, Bohumil Bednář, Circulation	1995	94
Acceleration of recombinant tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by the combination of heparin and the Arg-Gly-Asp-containing peptide bitistatin in a canine model of coronary thrombosis. Ronald J. Shebuski, I J Stabilito, Gary R. Sitko, Circulation Arg-gly-asp-containing Peptide BitistatinCoronary ThrombosisBiomedical EngineeringAcute Myocardial InfarctionThrombosis	1990	67
Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383. Joseph J. Lynch, Jacquelynn J. Cook, Gary R. Sitko, Journal of Pharmacology and Experimental Therapeutics	1995	67
Non-Peptide Glycoprotein IIb/IIIa Antagonists. 11. Design and <i>in Vivo</i> Evaluation of 3,4-Dihydro-1(1<i>H</i>)-isoquinolinone-Based Antagonists and Ethyl Ester Prodrugs John H. Hutchinson, Jacquelynn J. Cook, Karen M. Brashear, Journal of Medicinal Chemistry	1996	64
Non-Peptide Glycoprotein IIb/IIIa Inhibitors. 17. Design and Synthesis of Orally Active, Long-Acting Non-Peptide Fibrinogen Receptor Antagonists Benny C. Askew, Rodney A. Bednar, Bohumil Bednář, Journal of Medicinal Chemistry	1997	56
Non-Peptide GPIIb/IIIa Inhibitors. 20. Centrally Constrained Thienothiophene α-Sulfonamides Are Potent, Long Acting in Vivo Inhibitors of Platelet Aggregation Melissa S. Egbertson, Jacquelynn J. Cook, Bohumil Bednář, Journal of Medicinal Chemistry PharmacotherapyBiomedical EngineeringChemical BiologyPlatelet AggregationAdp-induced Platelet Aggregation	1999	50
Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics James C. Barrow, Philippe G. Nantermet, Shaun R. Stauffer, Journal of Medicinal Chemistry PharmacotherapyNovel AntithromboticsThrombosisMedicinal ChemistryHematology	2003	42
9-Hydroxyazafluorenes and Their Use in Thrombin Inhibitors Kenneth J. Stauffer, Peter Williams, Harold G. Selnick, Journal of Medicinal Chemistry	2005	36

Page 1